AAAAAA

   
Results: 1-10 |
Results: 10
Relationship between glutathione S-transferase M1, P1 and T1 polymorphismsand early onset prostate cancer
Authors: Kote-Jarai, Z Easton, D Edwards, SM Jefferies, S Durocher, F Jackson, RA Singh, R Ardern-Jones, A Murkin, A Dearnaley, DP Shearer, R Kirby, R Houlston, R Eeles, R
Citation: Z. Kote-jarai et al., Relationship between glutathione S-transferase M1, P1 and T1 polymorphismsand early onset prostate cancer, PHARMACOGEN, 11(4), 2001, pp. 325-330
No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours
Authors: Jefferies, S Edwards, SM Hamoudi, RA A'Hern, R Foulkes, W Goldgar, D Collaborators, MPT Eeles, R
Citation: S. Jefferies et al., No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours, BR J CANC, 85(9), 2001, pp. 1383-1386
A patient with 17 primary tumours and a germ line mutation in TP53: Tumourinduction by adjuvant therapy?
Authors: Nutting, C Camplejohn, RS Gilchrist, R Tait, D Blake, P Knee, G Yao, WQ Ross, G Fisher, C Eeles, R
Citation: C. Nutting et al., A patient with 17 primary tumours and a germ line mutation in TP53: Tumourinduction by adjuvant therapy?, CL ONCOL-UK, 12(5), 2000, pp. 300-304
Simultaneous breast cancer in non-identical Ashkenazi Jewish twins: Management dilemmas when genetic testing is negative
Authors: Sibtain, A Eeles, R Wellwood, J Plowman, PN
Citation: A. Sibtain et al., Simultaneous breast cancer in non-identical Ashkenazi Jewish twins: Management dilemmas when genetic testing is negative, CL ONCOL-UK, 12(5), 2000, pp. 305-308
Suggestive evidence for a site specific prostate cancer gene on chromosome1p36
Authors: Badzioch, M Eeles, R Leblanc, G Foulkes, WD Giles, G Edwards, S Goldgar, D Hopper, JL Bishop, DT Moller, P Heimdal, K Easton, D
Citation: M. Badzioch et al., Suggestive evidence for a site specific prostate cancer gene on chromosome1p36, J MED GENET, 37(12), 2000, pp. 947-948
Hereditary cancer
Authors: Ardern-Jones, A Eeles, R
Citation: A. Ardern-jones et R. Eeles, Hereditary cancer, CANCER NURSING: CARE IN CONTEXT, 2000, pp. 297-312
BRCA1/2 carriers and endocrine risk modifiers
Authors: Eeles, R Kadouri, L
Citation: R. Eeles et L. Kadouri, BRCA1/2 carriers and endocrine risk modifiers, ENDOCR-R CA, 6(4), 1999, pp. 521-528
BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas
Authors: Gill, S Broni, J Jefferies, S Osin, P Kovacs, G Maitland, NJ Eeles, R Edwards, SM Dyer, MJS Willis, TG Cooper, CS
Citation: S. Gill et al., BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas, BR J CANC, 80(10), 1999, pp. 1565-1568
The role of genetic factors in predisposition to squamous cell cancer of the head and neck
Authors: Jefferies, S Eeles, R Goldgar, D A'Hern, R Henk, JM Gore, M
Citation: S. Jefferies et al., The role of genetic factors in predisposition to squamous cell cancer of the head and neck, BR J CANC, 79(5-6), 1999, pp. 865-867
The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer
Authors: Watson, M Lloyd, S Davidson, J Meyer, L Eeles, R Ebbs, S Murday, V
Citation: M. Watson et al., The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer, BR J CANC, 79(5-6), 1999, pp. 868-874
Risultati: 1-10 |